癌症宿命论与美国西班牙裔新兴成年女性HPV疫苗接种相关
2020年8月至12月在美国西班牙裔18至26岁大学女性中开展横断面研究,完整病例分析纳入689人,采用调整logistic回归模型识别HPV疫苗接种相关因素。仅55.6%至少接种一剂HPV疫苗;HPV相关癌症知识与接种呈正相关(aOR=1.32;95%CI=1.18,1.47),癌症宿命论与接种呈负相关(aOR=0.97;95%CI=0.94,1.00)。作者认为该人群接种率低,需文化适配的干预策略。
要点
- 西班牙裔新兴成年女性至少接种一剂HPV疫苗的比例为55.6%。
- HPV相关癌症知识越高,接种可能性越高(aOR=1.32;95%CI=1.18,1.47)。
- 癌症宿命论越高,接种可能性越低(aOR=0.97;95%CI=0.94,1.00)。
核心结论
- 研究结果显示西班牙裔新兴成年女性HPV疫苗接种率低,有必要识别影响接种率的因素。
- 作者认为该人群存在关键且未满足的需求,需创新方法提高HPV疫苗接种并减少HPV相关癌症发生。
研究设计与样本
- 2020年8月至12月开展的横断面研究,对象为18至26岁西班牙裔大学女性。
- 完整病例分析纳入689名参与者,采用调整logistic回归模型识别HPV疫苗接种相关因素。
- 研究经参与大学机构审查委员会批准。
主要发现
- 研究人群中仅55.6%至少接种过一剂HPV疫苗。
- HPV疫苗接种与HPV相关癌症知识呈正相关(aOR=1.32;95%CI=1.18,1.47)。
- HPV疫苗接种与癌症宿命论呈负相关(aOR=0.97;95%CI=0.94,1.00)。
临床怎么用
- 作者建议实施文化适配的健康促进举措以减少该人群的宿命论信念。
- 作者建议制定文化适配、年龄特异性的HPV疫苗教育与促进项目以提高西班牙裔新兴成年人的HPV相关癌症知识。
- 作者认为需要多种干预策略以提高该人群的疫苗接种率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Despite the availability of the Human Papillomavirus (HPV) vaccine, only a small percentage of Hispanic emergent adults in the United States have actually had the vaccination. Due to cancer fatalism, some Hispanic emerging adults may perceive fewer benefits from the HPV vaccine, regardless of its positive health effects. The aim of this study was to determine the relationship between cancer fatalism, knowledge of HPV-associated cancers, and HPV vaccination among Hispanic emerging adult women. STUDY DESIGN: Between August and December of 2020, a cross-sectional study was conducted among Hispanic college women aged 18 to 26. A complete case study was conducted with 689 participants. Using an adjusted logistic regression model, the potential factors associated with HPV vaccine uptake were identified. The current research was approved by the Institutional Review Boards of the participating universities. RESULTS: Only 55.6 % of the study population had received at least one dose of the HPV vaccine. The study found that HPV vaccine uptake was positively associated with HPV associated cancer knowledge (aOR = 1.32; 95 % CI = 1.18, 1.47) and was inversely associated with cancer fatalism (aOR = 0.97; 95 % CI = 0.94, 1.00). CONCLUSION: According to the results of our study, the HPV vaccination rate among Hispanic emerging adult women is low, and it is necessary to identify the factors that influence vaccination rates. There is a critical, unmet need for innovative approaches to improve HPV vaccination in this population and mitigate the incidence of HPV-related cancers. IMPLICATIONS: Multiple intervention strategies are required to increase vaccination rates among this population. This study suggests implementing culturally tailored health promotion initiatives that reduce fatalistic beliefs among this population. Furthermore, developing a culturally tailored, age-specific HPV vaccine education and promotion program to increase HPV-associated cancer knowledge among Hispanic emerging adults.
引用
- Taskin T, Roncancio AM, Cano MÁ, et al. Cancer fatalism is associated with HPV vaccine uptake among Hispanic emerging adult women in the US. Vaccine. 2024. PMID: 39413491. doi:10.1016/j.vaccine.2024.126417
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。